Kathleen Behrens Insider Profile

18 Followers
Kathleen Behrens, Director at Sarepta Therapeutics, holds 406.51K shares in IGM Biosciences (Ticker: IGMS), holds 201.09K shares in Sarepta Therapeutics (Ticker: SRPT), holds 184.16K shares in MiMedx Group (Ticker: MDXG).
tipranks
Kathleen Behrens

Kathleen Behrens
Sarepta Therapeutics (SRPT)
Director

Ranked #1,971 out of 99,218 Corporate Insiders

Profitable Transactions

70%
7 out of 10 Profitable Transactions

Average Return

+54.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$33M
77.88%
17.94%
4.18%
A breakdown of Kathleen Behrens's holdings

Insider Roles

Sarepta Therapeutics
(SRPT)
Director
IGM Biosciences
(IGMS)
Director
MiMedx Group
(MDXG)
Director
Roles that Kathleen Behrens holds in companies

Most Profitable Insider Trade

Stock:
IGM Biosciences
(IGMS)
Rating:Informative Buy
Date:Sep 20, 2019 - Sep 20, 2020
Return:+291.90%
The most profitable trade made by Kathleen Behrens

Kathleen Behrens's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Sarepta Therapeutics
Sep 05, 2024
Director
Uninformative Sell
$25.73M
IGM Biosciences
Oct 02, 2024
Director
Uninformative Buy
$5.93M
MiMedx Group
Jun 06, 2024
Director
Uninformative Buy
168.36K
$1.38M
List of latest transactions for each holding click on a transaction to see Kathleen Behrens's performance on stock

Kathleen Behrens insider profile FAQ

What is the percentage of profitable transactions made by Kathleen Behrens?
The percentage of profitable transactions made by Kathleen Behrens is 70%.
    What is the average return per transaction made by Kathleen Behrens?
    The average return per transaction made by Kathleen Behrens is 54.90%.
      What stocks does Kathleen Behrens hold?
      Kathleen Behrens holds: SRPT, IGMS, MDXG stocks.
        What was Kathleen Behrens’s latest transaction?
        Kathleen Behrens latest transaction was an Uninformative Buy of ―.
          What was Kathleen Behrens's most profitable transaction?
          Kathleen Behrens’s most profitable transaction was an Informative Buy of IGMS stock on September 20, 2019. The return on the trade was 291.90%.
            What is Kathleen Behrens's role in Sarepta Therapeutics?
            Kathleen Behrens's role in Sarepta Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.